Is the persistent sodium current a specific target of anti-absence drugs?

NeuroReport

Volumn 15, Issue 6, 2004, Pages 1049-1052

  Niespodziany, Isabelle ^a   Klitgaard, Henrik ^a   Margineanu, Doru Georg ^a  

^a UCB PHARMA   (Belgium)

Author keywords

Anti absence drugs; Antiepileptic drugs; Ethosuximide; Hippocampal neurons; Levetiracetam (Keppra ); Persistent Na+ current

Indexed keywords

ETHOSUXIMIDE; ETIRACETAM; PHENYTOIN; RILUZOLE; VALPROIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TARGETING; HIPPOCAMPUS; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SODIUM CURRENT; TREATMENT FAILURE; VOLTAGE CLAMP;

ACTION POTENTIALS; ANIMALS; ANTICONVULSANTS; DRUG DELIVERY SYSTEMS; HIPPOCAMPUS; MALE; RATS; SODIUM CHANNELS;

EID: 2342573680     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200404290-00023     Document Type: Article

References (24)

1. Manning JP, Richards DA and Bowery NG. Pharmacology of absence epilepsy. Trends Pharmacol Sci 24, 542-549 (2003).
2. Coulter DA, Huguenard JR and Prince DA. Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann Neurol 25, 582-593 (1989).
3. Leresche N, Parri HR, Erdemli G, Guyon A, Turner JP, Williams SR et al. On the action of the anti-absence drug ethosuximide in the rat and cat thalamus. J Neurosci 18, 4842-4853 (1998).
4. 2+ currents. Seizure 10, 279-286 (2001).
5. + current in neocortical neurons Levetiracetam: mechanisms of action. Epilepsy Res 32, 304-308 (1998).
6. French CR, Sah P, Buckett KJ and Gage PW. A voltage-dependent persistent sodium current in mammalian hippocampal neurons. J Gen Physiol 95, 1139-1157 (1990).
7. + currents: a new family of receptor-operated inward currents in mammalian nerve cells. Brain Res Brain Res Rev 25, 246-254 (1997).
8. + currents that fail to inactive. Trends Neurosci 16, 455-460 (1993).
9. + current of rat CA1 neurons. Program No 798. 3 Abstract Viewer/Itinerary Planner Washington, DC: Society for Neuroscience, 2002. Online.
10. + current. J Pharmacol Exp Ther 284, 228-237 (1998).
11. Urbani A and Belluzzi O. Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur J Neurosci 12, 3567-3574 (2000).
12. Spadoni F, Hainsworth AH, Mercuri NB, Caputi L, Martella G, Lavaroni F et al. Lamotrigine derivatives and riluzole inhibit INa,P in cortical neurons. Neuroreport 13, 1167-1170 (2002).
13. Crill WE. Persistent sodium current in mammalian central neurons. Annu Rev Physiol 58, 349-362 (1996).
14. Alkadhi KA and Tian LM. Veratridine-enhanced persistent sodium current induces bursting in CA1 pyramidal neurons. Neuroscience 71, 625-632 (1996).
15. Bensimon G, Lacomblez L and Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 330, 585-591 (1994).
16. Zona C, Siniscalchi A, Mercuri NB and Bernardi G. Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons. Neuroscience 85, 931-938 (1998).
17. Siniscalchi A, Bonci A, Mercuri NB and Bernardi G. Effects of riluzole on rat cortical neurones: an in vitro electrophysiological study. Br J Pharmacol 120, 225-230 (1997).
18. Segal MM and Douglas AF. Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin. J Neurophysiol 77, 3021-3034 (1997).
19. Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ and Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 55, 236-242 (2000).
20. Gower AJ, Hirsch E, Boehrer A, Noyer M, Marescaux C. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res 22, 207-213 (1995).
21. Klitgaard H, Matagne A, Gobert J and Wulfert E. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol 353, 191-206 (1998).
22. Rigo JM, Hans G, Nguyen L, Rocher V, Balachew S, Malgrange B et al. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 136, 659-672 (2002).
23. Margineanu DG and Klitgaard H. Levetiracetam: mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS et al. (eds). Antiepileptic drugs, 5th edn. Philadelphia: Lippincott Williams and Wilkins; 2002, pp. 419-427.
24. Margineanu DG and Klitgaard H. Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs. Pharmacol Res 42, 281-285 (2000).